08Oct
08Oct
Blind nursing student awarded with eSight glasses to see
First-year nursing student Emma Van Dyk, who is legally blind, is one of five Canadian students awarded with a medical vision-assistive device from eSight, to help her see. Van Dyk wants to bring awareness to sight loss, saying it’s not a disability, it's just a different ability. Read more >>
07Oct
Corbus Pharmaceuticals Announces Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis Did Not Meet Primary Endpoint
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced topline results from its 28-week Phase 2b study of lenabasum in patients with cystic fibrosis (CF). The study enrolled patients in the U.S., Canada and Europe at high risk for recurrent pulmonary exacerbations (PEx). Subjects received lenabasum or placebo added to their background treatments for CF. Read more >>
06Oct
Elite Athletes Use ZetrOZ Systems’ sam® Technology to Heal Quicker and Avoid Surgery
sam® ultrasound, ZetrOZ Systems' sustained acoustic medicine device, is the preferred healing solution of countless professional and collegiate athletes. The wearable, long-duration ultrasound technology helps athletes avoid surgery while accelerating natural healing, proving to be extremely valuable in cases of acute and chronic pain, especially those that involve soft tissue damage. Read more >>
03Oct
This New Canned Orange Wine Will Get Me Through Fall
So when I got an opportunity to sample the new Archer Roose limited release skin-macerated canned orange wine, I said “bring it on!” Upon my first sip, I can now say I’m forever a stan of Archer Roose Canned Rodí Rosé. Read more >>
02Oct
Oncocyte Agrees to Enter Licensing and Collaboration Agreement with Chronix Biomedical
Oncocyte Corporation, a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced that it has agreed to enter a licensing and collaboration agreement with Chronix Biomedical. Oncocyte is licensing Chronix’s patented CNI Monitor technology for the TheraSure™-CNI MONITOR clinical assay. Read more >>
30Sep
XYLYX BIO launches specialized contract R&D services that increase predictiveness in antifibrotic drug discovery
Xylyx Bio, a leader in advanced disease models for drug discovery, today announced the launch of specialized contract R&D services that support improved assessment of antifibrotic drug candidate efficacy. Despite ongoing advances, the current drug discovery paradigm is highly inefficient. Read more >>
29Sep
The 100 People You Don’t Know But Should 2020
Sue Nolin VP, Inside Sales, Wasabi Technologies -- When it comes to growing sales and its channel team, Wasabi turns to Nolin. She is constantly working to up the cloud storage vendor’s game when it comes to supporting solution providers’ sales efforts every day. She knows the channel is key to her and Wasabi’s success. Read more >>
29Sep
Cognoptix Revitalizes, Appoints New Chief Executive Officer Dr. Susanne Wilke, PhD, Raises Oversubscribed $2.6m Series R
Cognoptix, a healthcare company developing the Sapphire II System, a breakthrough technology for early detection of Alzheimer's disease (AD), announces the closing of an over-subscribed Series R financing round. Cognoptix has undergone a complete revitalization over the past year. Read more >>
26Sep